Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2026-01-04 @ 5:38 PM
Study NCT ID:
NCT03068351
Status:
COMPLETED
Last Update Posted:
2020-02-07
First Post:
2017-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Bromodomain and Extra-Terminal Protein (BET) Inhibitor RO6870810 as Mono- and Combination Therapy in Advanced Multiple Myeloma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-26
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-27
First Submit QC Date:
None
Study First Post Date:
2017-03-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-02-06
Last Update Post Date:
2020-02-07
Last Update Post Date Type:
ACTUAL